1-20 of 80
Jehan Dupuis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inflammatory Waldenström Macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohort

Pierre-Edouard Debureaux, Stéphanie Poulain, Stephanie Harel, Marie Passet, Marie Templé, Chloe Friedrich, Nathalie Forgeard, Dikelele Elessa, William Plas, Laureen Chat, Gregory Lazarian, Lise Willems, Bruno Royer, Alexis Talbot, Tristan Vaugeois, Dr., Floriane Theves, Alexandre Terré, Anne C. Brignier, Marion Malphettes, Daphné Krzisch, Laurent Frenzel, Frédéric Davi, Clotilde Bravetti, Florence Nguyen-Khac, Jehan Dupuis, Wendy Cuccuini, Didier Bouscary, Olivier Hermine, Damien Roos-Weil, Olivier Kosmider, Emmanuelle Clappier, Marion Espéli, Karl Balabanian, Bertrand Arnulf
Journal: Blood
Blood blood.2024025738.
https://doi.org/10.1182/blood.2024025738
Published: 2024
Includes: Supplemental data
Journal Articles

Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Final Results of the Eradic Trial from the Filo Group

Anne Sophie Michallet, Remi Letestu, Magali Legarff, Stéphane Morisset, Therese Aurran-Schleinitz, Kamel Laribi, Vincent Levy, Laurence Simon, Damien Roos Weil, Marie Sarah Dilhuydy, Cecile Tomowiak, Caroline Dartigeas, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie De Guibert, Pierre Feugier, Fatiha Merabet, Stéphane Lepretre, Philippe Carassou, Julie Gay, Benedicte Hivert, Luc-Matthieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Omar Benbrahim, Xavier Cahu, Florence Nguyen Khac, Valerie Rouillé, Loic Ysebaert, Anne Quinquenel
Journal: Blood
Blood (2024) 144 (Supplement 1): 584.
https://doi.org/10.1182/blood-2024-194593
Published: 2024
Journal Articles

Inflammatory Waldenström Macroglobulinemia Is Associated with Clonal Hematopoiesis: A Multicentric Cohort

Pierre-Edouard Debureaux, Stephanie Poulain, Marie Passet, Marie Temple, Chloé Friedrich, Nathalie Forgeard, Dikelele Elessa, William Plas, Laureen Chat, Gregory Lazarian, Lise Willems, Bruno Royer, Alexis Talbot, Tristan Vaugeois, Floriane Theves, Alexandre Terre, Anne Brignier, Marion Malphettes, Daphne Krzisch, Laurent Frenzel, Frederic Davi, Clothilde Bravetti, Florence Nguyen-Khac, Jehan Dupuis, Wendy Cuccuini, Didier Bouscary, Olivier Hermine, Damien Roos-Weil, Olivier Kosmider, Emmanuelle Clappier, Marion Espeli, Karl Balabanian, Bertrand Arnulf
Journal: Blood
Blood (2024) 144 (Supplement 1): 4343.
https://doi.org/10.1182/blood-2024-193883
Published: 2024
Journal Articles

Preemptive Therapy with Venetoclax for High-Risk Stage a CLL Patients: First Analysis of Prevene, a Phase II Trial of the Filo Group

Luc-Matthieu Fornecker, Rémi Letestu, Nanthara Shritaran, Emmanuelle Ferrant, Fressia Honeyman, Therese Aurran-Schleinitz, Fatiha Merabet, Pierre Morel, Abderrazak El Yamani, Jehan Dupuis, Kamel Laribi, Stephane Lepretre, Lysiane Molina, Hugo Legendre, Chadi Al Nawakil, Bruno Villemagne, Anne-Sophie Michallet, Béatrice Mahé, Omar Benbrahim, Laurence Sanhes, Caroline Dartigeas, Aline Clavert, Vincent Levy
Journal: Blood
Blood (2024) 144 (Supplement 1): 3256.
https://doi.org/10.1182/blood-2024-203081
Published: 2024
Journal Articles

Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Interim Results of MRD Kinetics in the Eradic Trial from the Filo Group

Anne-Sophie Michallet, Anne Quinquenel, Remi Letestu, Tavernier Magali, Stéphane Morisset, Therese Aurran, Kamel Laribi, Florence Cymbalista, Vincent Levy, Laurence Simon, Damien Roos Weil, Veronique Leblond, Marie Sarah Dilhuydy, Cecile Tomowiak, Caroline Dartigeas, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie De Guibert, Pierre Feugier, Fatiha Merabet, Stéphane Lepretre, Philippe Carassou, Julie Gay, Benedicte Hivert, Luc Matthieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Béatrice Mahé, Omar Benbrahim, Xavier Cahu, Christelle Portois, Loic Ysebaert, Florence Nguyen Khac, Valerie Rouillé, Alain Jacques Delmer
Journal: Blood
Blood (2023) 142 (Supplement 1): 3268.
https://doi.org/10.1182/blood-2023-173341
Published: 2023
Journal Articles

Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation

Anne Quinquenel, Rémi Letestu, Magali Le Garff-Tavernier, Fabien Subtil, Therese Aurran-Schleinitz, Kamel Laribi, Florence Cymbalista, Vincent Levy, Laurence Simon, Damien Roos-Weil, Véronique Leblond, Marie-Sarah Dilhuydy, Caroline Dartigeas, Cecile Tomowiak, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie de Guibert, Pierre Feugier, Fatiha Merabet, Stephane Lepretre, Philippe Carassou, Julie Gay, Bénédicte Hivert, Luc Mathieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Béatrice Mahé, Omar Benbrahim, Xavier Cahu, Christelle Portois, Loic Ysebaert, Florence Nguyen Khac, Valérie Rouille, Alain Delmer, Anne-Sophie Michallet
Journal: Blood
Blood (2022) 140 (Supplement 1): 7007–7009.
https://doi.org/10.1182/blood-2022-159678
Published: 2022
Journal Articles

Long-Term Follow-up of Bendamustine Plus Rituximab Regimen in 69 Treatment Naïve (TN) Patients with Waldenström Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Kamel Laribi, Stéphanie Poulain, Lise Willems, Fatiha Merabet, Charles Herbaux, Damien Roos Weil, Alix Baugier de Materre, Xavier Roussel, Sabine Tricot, Jehan Dupuis, Ronan Le Calloch, Benoit Bareau, Marie C Béné, Veronique Leblond
Journal: Blood
Blood (2022) 140 (Supplement 1): 3627–3628.
https://doi.org/10.1182/blood-2022-157394
Published: 2022
Journal Articles

The ALK-OBS Trial: Results of a Multicenter Prospective Study Assessing the Prognostic Value of New Markers in Adults with ALK-Positive ALCL Treated By CHOEP: A Lysa Study

David Sibon, Laurence Lamant, Véronique Vergé, Loic Ysebaert, Catherine Thieblemont, Krimo Bouabdallah, Jehan Dupuis, Rémy Gressin, Emmanuel Bachy, Yann Guillermin, Nicolas Daguindau, Charlotte Syrykh, Choquet Sylvain, Pierre Feugier, Caroline Delette, Olivier Casasnovas, Marlene Ochmann, Ronan Le Calloch, Emmanuel Gyan, Herve Tilly, Gandhi Laurent Damaj, Olivier Tournilhac
Journal: Blood
Blood (2022) 140 (Supplement 1): 3680–3682.
https://doi.org/10.1182/blood-2022-170841
Published: 2022
Journal Articles

Oral Azacytidine in Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: Final Analysis of the Oracle Phase III Study

Jehan Dupuis, Kunihiro Tsukasaki, Emmanuel Bachy, Franck Morschhauser, Guillaume Cartron, Noriko Fukuhara, Nicolas Daguindau, René-Olivier Casasnovas, Sylvia Snauwaert, Rémy Gressin, Christopher P. Fox, Francesco Annibale d'Amore, Philipp B. Staber, Argyrios Gkasiamis, Mitsufumi Nishio, Luc-Matthieu Fornecker, Marie-Helene Delfau, Nouhoum Sako, Sebastien Mule, Laurence De Leval, Philippe Gaulard, Francois Lemonnier
Journal: Blood
Blood (2022) 140 (Supplement 1): 2310–2312.
https://doi.org/10.1182/blood-2022-156789
Published: 2022
Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Olivier Tournilhac, Solene Lecolant, Maya Hacini, Krimo Bouabdallah, Sebastien Bailly, Kamel Laribi, Thibaut Belmondo, Marie Maerevoet, Loic Ysebaert, Stéphanie Guidez, Steven Le Gouill, Christophe Bonnet, Marc Andre, Jehan Dupuis, Catherine Thieblemont, Emmanuel Bachy, Nicolas Daguindau, Franck Morschhauser, Sabine Tricot, Pierre Feugier, Anne Banos, Thierry Lamy, Adrien Chauchet, Emmanuel Gyan, Guillaume Cartron, Hassan Farhat, Vincent Camus, Bernard Drenou, Hacene Zerazhi, David Sibon, Emmanuelle Nicolas-Virelizier, Caroline Delette, Sylvia Snauwaert, Nicole Straetmans, Richard Delarue, Marie Parrens, Samuel Griolet, Philippe Gaulard, Marie-Helene Delfau-Larue, Laurence De Leval, Gandhi Laurent Damaj
Journal: Blood
Blood (2022) 140 (Supplement 1): 2302–2305.
https://doi.org/10.1182/blood-2022-165217
Published: 2022
Journal Articles

High Frequency of CNS Involvement in Transformed Waldenström Macroglobulinemia

Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, Elise Toussaint, Efstathios Kastritis, Shirley D'Sa, Miguel Alcoceba, Cécile Tomowiak, Bénédicte Hivert, Caroline Protin, Jithma P. Abeykoon, Josephine M.I. Vos, Anne-Sophie Michallet, Cyrielle Rodier, Jehan Dupuis, Stéphane Leprêtre, Fatiha Merabet, Xavier Roussel, Jean-Marc Zini, Caroline Regny, Aisha S Patel, Pierre Morel, Damien Roos-Weil, Steven P. Treon, Meletios A. Dimopoulos, Ramon Garcia-Sanz, Prashant Kapoor, Jorge J. Castillo, Alain Delmer
Journal: Blood
Blood (2021) 138 (Supplement 1): 2526.
https://doi.org/10.1182/blood-2021-145440
Published: 2021
Journal Articles

Total Metabolic Tumor Volume and Tumor Dissemination Are Independent Prognostic Factors in Advanced Hodgkin Lymphoma

Salim Kanoun, Alina Berriolo-Riedinger, Anne Ségolène Cottereau, Veronique Edeline, Ilan Tal, Pauline Brice, Reda Bouabdallah, Herve Ghesquieres, Aspasia Stamatoullas-Bastard, Jehan Dupuis, Marc André, Thomas Gastinne, Julien Lazarovici, Samuel Griolet, Cedric Rossi, Michel Meignan, Rene-Olivier Casasnovas
Journal: Blood
Blood (2021) 138 (Supplement 1): 880.
https://doi.org/10.1182/blood-2021-147177
Published: 2021
Journal Articles

Integrative Study of a High-Grade B-Cell Lymphoma Cohort of 45 Patients: A Single Institution Real Life Study

Louise Roulin, Elsa Poullot, Paul Blanc-Durand, Cyrielle Robe, Francois Lemonnier, Fabien Le Bras, Romain Gounot, Karim Belhadj, Jehan Dupuis, Mohammad Hammoud, Taoufik El Gnaoui, Sebastien Mule, Christiane Copie Bergman, Thierry Molina, Marie Helene Delfau Larue, Emmanuel Itti, Philippe Gaulard, Corinne Haioun
Journal: Blood
Blood (2021) 138 (Supplement 1): 4576.
https://doi.org/10.1182/blood-2021-152627
Published: 2021
Journal Articles

Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR

Anne-Sophie Michallet, Anne Quinquenel, Remi Letestu, Magali Le Garff-Tavernier, Fabien Subtil, Mad-Helenie Elsensohn, Therese Aurran, Kamel Laribi, Florence Cymbalista, Vincent Levy, Laurence Simon, Damien Roos-Weil, Veronique Leblond, Marie-Sarah Dilhuydy, Cécile Tomowiak, Caroline Dartigeas, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie de Guibert, Pierre Feugier, Fatiha Merabet, Stéphane Leprêtre, Philippe Carassou, Julie Gay, Bénédicte Hivert, Luc Mathieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Béatrice Mahé, Omar Benbrahim, Xavier Cahu, Christelle Portois, Loic Ysebaert, Florence Nguyen-Khac, Valérie Rouille, Alain Delmer
Journal: Blood
Blood (2021) 138 (Supplement 1): 641.
https://doi.org/10.1182/blood-2021-145624
Published: 2021
Journal Articles

Up-front carfilzomib, lenalidomide, and dexamethasone with transplant for patients with multiple myeloma: the IFM KRd final results

Clinical Trials & Observations
Murielle Roussel, Valerie Lauwers-Cances, Soraya Wuilleme, Karim Belhadj, Salomon Manier, Laurent Garderet, Martine Escoffre-Barbe, Clara Mariette, Lotfi Benboubker, Denis Caillot, Cécile Sonntag, Cyrille Touzeau, Jehan Dupuis, Philippe Moreau, Xavier Leleu, Thierry Facon, Benjamin Hébraud, Jill Corre, Michel Attal
Journal: Blood
Blood (2021) 138 (2): 113–121.
https://doi.org/10.1182/blood.2021010744
Published: 2021
Journal Articles

BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia

Charles Herbaux, Christoph Kornauth, Stéphanie Poulain, Stephen J. F. Chong, Mary C. Collins, Rebecca Valentin, Liam Hackett, Olivier Tournilhac, François Lemonnier, Jehan Dupuis, Adrien Daniel, Cecile Tomowiak, Kamel Laribi, Loïc Renaud, Damien Roos-Weil, Cedric Rossi, Eric Van Den Neste, Cecile Leyronnas, Fatiha Merabet, Jean Valère Malfuson, Mourad Tiab, Loïc Ysebaert, Samuel Ng, Franck Morschhauser, Philipp B. Staber, Matthew S. Davids
Journal: Blood
Blood (2021) 137 (25): 3495–3506.
https://doi.org/10.1182/blood.2020007303
Published: 2021
Includes: Supplemental data
Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Results of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Olivier Tournilhac, MD PhD, Maya Hacini, MD, Kamal Bouabdallah, MD, Kamel Laribi, MD, Marie Maerevoet, MD, Loic Ysebaert, MD PhD, Stephanie Guidez, Steven Le Gouill, MD PhD, Marc André, MD, Jehan Dupuis, MD, Catherine Thieblemont, MD PhD, Emmanuel Bachy, MD PhD, Nicolas Daguindau, MD, Franck Morschhauser, MD PhD, Sabine Tricot, MD, Pierre Feugier, MD PhD, Anne Banos, MD, Thierry Lamy De La Chapelle, MD PhD, Adrien Chauchet, MD, Emmanuel Gyan, MD PhD, Guillaume Cartron, MD PhD, Hassan Farhat, MD, Vincent Camus, Bernard Drenou, MD PhD, Hacene Zerazhi, MD, David Sibon, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Caroline Delette, MD, Sylvia Snauwaert, MD, Nicole Straetmans, MD, Richard Delarue, MD, Marie Parrens, MD, Céline Bossard, MD, Laurence De Leval, MD, Philippe Gaulard, MD PhD, Gandhi Laurent Damaj, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-139224
Published: 2020
Journal Articles

PET-Guided Strategy Improves the Safety of Beacopp-Based Treatment in Advanced Hodgkin Lymphoma: Prolonged Follow-up of the Lysa Ahl 2011 Phase 3 Study

Olivier Casasnovas, MD, Judith Racape, MD, Julie Dechene, Reda Bouabdallah, MD, Pauline Brice, MD, Julien Lazarovici, MD, Hervé Ghesquieres, MD PhD, Aspasia Stamatoulas Bastard, MD, Jehan Dupuis, MD, Anne-Claire Gac, MD, Thomas Gastinne, MD, Bertrand Joly, MD, Krimo Bouabdallah, MD, Emmanuelle Nicolas-Virelizier, MD, Pierre Feugier, MD, Franck Morschhauser, MD PhD, Marc André, MD, Alina Berriolo-Riedinger, MD, Veronique Edeline, MD, Clémentine Joubert, PhD, Michel Meignan, MD, Isabelle Demeestere, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-136056
Published: 2020
Journal Articles

Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Long-Term Efficacy and Safety Results from a Phase 2 Study

Michael Wang, MD, Simon Rule, MD PhD, Pier Luigi Zinzani, MD, Andre H. Goy, MD, Rene-Olivier Casasnovas, MD, Stephen D. Smith, MD, Gandhi Laurent Damaj, MD PhD, Jeanette K. Doorduijn, MD PhD, Thierry Lamy, Franck Morschhauser, MD PhD, Carlos Panizo, MD PhD, Bijal Shah, MD, Andrew Davies, MD PhD, Richard Eek, FRACP., Jehan Dupuis, MD, Eric Jacobsen, MD, Arnon P. Kater, MDPhD, Steven Le Gouill, MD PhD, Lucie Oberic, MD, Tadeusz Robak, MDPhD, Preetesh Jain, MBBS,MDDM,PhD, Graham Brock, PhD, Priti Patel, MD, Lin Tao, Monika Dlugosz-Danecka, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-134824
Published: 2020
Journal Articles

Rituximab Plus Gemcitabine and Oxaliplatin (R-GemOx) in Refractory/Relapsed (R/R) DLBCL. a Real Life Study in Patients Ineligible for Autologous Transplantation

Clarisse Cazelles, Karim Belhadj, Helene Vellemans, Vincent Camus, Christiane Copie, MD PhD, Liana Veresezan, MD, Emmanuel Itti, MD PhD, Stephanie Becker, MD, Muriel verlinde Carvalho, Jehan Dupuis, MD, Fabien Le Bras, Francois Lemonnier, MD PhD, Louise Roulin, MD, Taoufik El Gnaoui, Fabrice Jardin, Nicolas Mounier, MD, Herve Tilly, MD PhD, Corinne Haioun, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4115.
https://doi.org/10.1182/blood-2019-124143
Published: 2019